David Kirske
Director of Finance/CFO chez CTI BIOPHARMA CORP.
Profil
David H.
Kirske is currently the CFO, Secretary & Executive Vice President at CTI BioPharma Corp.
He previously held positions as the Chief Financial Officer & Vice President at Helix BioMedix, Inc., Treasurer & Controller at Redhook Ale Brewery, Inc., and Treasurer & Controller at F5, Inc. Mr. Kirske completed his undergraduate degree at the University of Puget Sound.
Postes actifs de David Kirske
| Sociétés | Poste | Début |
|---|---|---|
| CTI BIOPHARMA CORP. | Director of Finance/CFO | 26/09/2017 |
Anciens postes connus de David Kirske
| Sociétés | Poste | Fin |
|---|---|---|
| HELIX BIOMEDIX, INC. | Director of Finance/CFO | 23/06/2008 |
| Redhook Ale Brewery, Inc. | Comptroller/Controller/Auditor | - |
| F5, INC. | Comptroller/Controller/Auditor | - |
Formation de David Kirske
| University of Puget Sound | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HELIX BIOMEDIX, INC. | Health Technology |
| F5, INC. | Technology Services |
| Entreprise privées | 2 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
| Redhook Ale Brewery, Inc. | Consumer Non-Durables |
